Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.
IPO Date: March 21, 2013
Sector: Healthcare
Industry: Biotech
Market Cap: $421.39M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.90 | 2.27%
Avg Daily Range (30 D): $0.23 | 1.91%
Avg Daily Range (90 D): $0.38 | 4.11%
Institutional Daily Volume
Avg Daily Volume: .2M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .5M
Trade Size
Avg Trade Size (Sh.): 73
Avg Trade Size (Sh.) (30 D): 67
Avg Trade Size (Sh.) (90 D): 79
Institutional Trades
Total Inst.Trades: 2,610
Avg Inst. Trade: $1.78M
Avg Inst. Trade (30 D): $.88M
Avg Inst. Trade (90 D): $.87M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.91M
Avg Closing Trade (30 D): $.55M
Avg Closing Trade (90 D): $.91M
Avg Closing Volume: 38.62K
   
News
Sep 29, 2025 @ 5:35 PM
10 Health Care Stocks With Whale Alerts In Today's...
Source: Benzinga Staff Writer
Sep 29, 2025 @ 5:28 PM
Enanta's RSV Pill Shows Promise In Cutting Recover...
Source: Vandana Singh
Sep 29, 2025 @ 5:06 PM
12 Health Care Stocks Moving In Monday's Intraday ...
Source: Benzinga Staff Writer
Sep 26, 2025 @ 9:06 PM
12 Health Care Stocks Moving In Friday's After-Mar...
Source: Benzinga Staff Writer
Jun 11, 2025 @ 9:07 PM
FDA Expands AbbVie's Mavyret Label To Include Acut...
Source: Vandana Singh
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-3.84 $-3.84
Diluted EPS $-3.84 $-3.84
Revenue $ 65.32M $ $ 65.32M
Gross Profit $ $ $
Net Income / Loss $ -81.89M $ $ -81.89M
Operating Income / Loss $ -85.35M $ $ -85.35M
Cost of Revenue $ $ $
Net Cash Flow $ -5.54M $ $ -5.54M
PE Ratio